Nutritional rickets or vitamin D–deficiency rickets | Vitamin D deficiency, phosphorus or calcium deficiency (rare), inadequate sunlight exposure, secondary to malabsorption syndromes (IBD, celiac disease, cystic fibrosis [rarely]) | NA | Skeletal findings, abnormal gait, hypocalcemic tetany/seizures, developmental delay, failure to thrive | Replace the deficient nutrient orally; may need to administer vitamin D intramuscularly if rickets secondary to malabsorption. |
Vitamin D–dependent rickets |
Type I or pseudovitamin D–deficiency rickets | Deficiency of renal 25(OH) D3–1-α-hydroxylase | Autosomal recessive | Younger than two years, hypocalcemic tetany, severe bony changes, seizures | Calcitriol (Rocaltrol) |
Type II or hereditary 1-α, 25-dihydroxyvitamin D–resistant rickets | Defective interaction between calcitriol and receptor | Autosomal recessive | Younger than one year, severe bony changes, alopecia | Massive doses of calcitriol and calcium |
Vitamin D–resistant rickets |
Familial hypophosphatemic rickets or X-linked hypophosphatemic rickets | Impaired proximal renal tubular reabsorption of phosphorus and inappropriately normal calcitriol levels | X-linked dominant | Short stature, leg bowing, dental abnormalities | Oral phosphate and calcitriol |
Hereditary hypophosphatemic rickets with hypercalciuria | Impaired proximal renal tubular reabsorption of phosphorus and increased calcitriol | Autosomal recessive, autosoma dominant | Bone pain, muscular weakness | Oral phosphate |
Miscellaneous |
Renal rickets or renal osteodystrophy | Loss of functional renal parenchyma caused by chronic renal failure leads to mineral derangements and decreased calcitriol production | NA | Bone pain, arthralgias, fractures, muscle weakness, failure to thrive | Vitamin D and phosphate- binding compound |
Rickets of prematurity | Multifactorial | NA | Osteopenia, fractures | Replace dietary deficiencies and minimize iatrogenic causes. |
Tumor-induced or oncogenic rickets | Tumor-induced inhibition of renal 25(OH)D3–1-α-hydroxylase | NA | Fractures, bone pain, muscle weakness | Treat underlying malignancy. |